Antitumour efficacy of the selumetinib and trametinib MEK inhibitors in a combined human airway–tumour–stroma lung cancer modelChristophe Mas, Samuel Constant, Song Huang et al.|Journal of Biotechnology|2015Cited by 24
Establishment of a Tumour–Stroma Airway Model (OncoCilAir) to Accelerate the Development of Human Therapies against Lung CancerChristophe Mas, Samuel Constant, Mireille Caul Futy et al.|Alternatives to Laboratory Animals|2016Cited by 12
Colon Cancer: Current Treatments and Preclinical Models for the Discovery and Development of New TherapiesSamuel Constant, Christophe Mas, Song Huang et al.|Drug Discovery|2013Cited by 10
Advanced Human In vitro Models for the Discovery and Development of Lung Cancer TherapiesSamuel Constant, Christophe Mas, Song Huang et al.|InTech eBooks|2015Cited by 5
Genetic engineering of a 3D in vitro human airway model sensitive to carcinogensHugo Benainous, Christophe Mas, Samuel Constant et al.|Toxicology Letters|2017Cited by 1